all report title image
  • Published In : Apr 2024
  • Code : CMI6855
  • Pages : 172
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to exhibit a CAGR of 8.6% during the forecast period (2024-2031). Iron deficiency anemia is a very common nutritional deficiency that affects over a billion people worldwide, according to the World Health Organization. It occurs when the body does not have enough iron to produce hemoglobin, an essential protein in red blood cells that carries oxygen throughout the body. Symptoms can vary from fatigue and weakness to headaches, dizziness, and breathlessness. Left untreated, it can be a serious health condition and negatively impact physical and cognitive development especially in infants, young children and women. Global iron deficiency anemia treatment market is witnessing strong growth with emergence of new oral and injectable drugs having less side effects and higher efficacy.

Market Dynamics:

Global iron deficiency anemia treatment market growth is driven by growing prevalence of the condition globally especially among children and women. Key factors contributing to rising cases of iron deficiency anemia include poor dietary intake of iron-rich foods, blood loss during menstruation, and parasitic infections. According to WHO, approximately 40% of pregnant women worldwide suffer from anemia, which is expected to propel demand for effective therapeutic drugs. Development of novel drugs by leading players is a significant growth opportunity in this space. However, availability of alternative treatment options including supplements and plant-based remedies in developing economies can restrain commercial uptake of modern medications to some extent in the near future.

Key Features of the Study:

  • This report provides in-depth analysis of the global iron deficiency anemia treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global iron deficiency anemia treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study includes AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., and American Regent, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global iron deficiency anemia treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron deficiency anemia treatment market

Detailed Segmentation-

  • Drug Type:
    • Ferrous Sulfate
    • Ferrous Gluconate
    • Ferrous Fumerate
    • Ferric Hydroxide
    • Others
  • Dosage Form:
    • Tablets
    • Capsules
    • Liquid
    • Others
  • Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • AdvaCare Pharma
    • Otsuka Pharmaceutical Co., Ltd.
    • Sanofi
    • Emcure Pharmaceuticals
    • Wellona Pharma
    • SiNi Pharma Pvt Ltd
    • Sun Pharmaceutical Industries Ltd.
    • Zydus Group
    • Akebia Therapeutics.
    • Rockwell Medical, Inc.
    • AbbVie Inc.
    • Pfizer, Inc.
    • Velnex Medicare 
    • PHAEDRUS LIFE SCIENCE PVT. LTD. 
    • Inopha International Co, Limited
    • PharmaNutra S.p.A.
    • Pharmascience Inc.
    • American Regent, Inc.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Dosage Form
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Developments
    • Acquisitions and Partnerships Scenario
    • Reimbursement scenario
    • Regulatory Scenario
    • Pricing Analysis
    • Brand Analysis
    • PEST Analysis
  4. Global Iron Deficiency Anemia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the market
  5. Global Iron Deficiency Anemia Treatment Market, By Drug Type, 2019 – 2031, (US$ Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Ferrous Sulfate
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Ferrous Gluconate
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Ferrous Fumerate
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Ferric Hydroxide
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
  6. Global Iron Deficiency Anemia Treatment Market, By Dosage Form, 2019 – 2031, (US$ Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Tablets
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Capsules
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Liquid
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
  7. Global Iron Deficiency Anemia Treatment Market, By Distribution Channel, 2019 – 2031, (US$ Bn)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Bn)
  8. Global Iron Deficiency Anemia Treatment Market, By Region, 2019 – 2031, (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Region, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • AdvaCare Pharma *
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Emcure Pharmaceuticals
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Wellona Pharma
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • SiNi Pharma Pvt Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Zydus Group
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Akebia Therapeutics.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Rockwell Medical, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • AbbVie Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Pfizer, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Velnex Medicare 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • PHAEDRUS LIFE SCIENCE PVT. LTD. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Inopha International Co, Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • PharmaNutra S.p.A.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • Pharmascience Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies           
      • American Regent, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  10. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 38 figures on "Iron Deficiency Anemia Treatment Market” -Global forecast to 2031

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo